Complex interplay between tumor microenvironment and cancer therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complex interplay between tumor microenvironment and cancer therapy
Authors
Keywords
tumor microenvironment, therapy response, treatment resistance
Journal
Frontiers of Medicine
Volume 12, Issue 4, Pages 426-439
Publisher
Springer Nature America, Inc
Online
2018-08-10
DOI
10.1007/s11684-018-0663-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics
- (2018) Qin Chen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Validating the pivotal role of the immune system in low-dose radiation-induced tumor inhibition in Lewis lung cancer-bearing mice
- (2018) Lei Zhou et al. Cancer Medicine
- Extracellular matrix remodeling in vivo for enhancing tumor-targeting efficiency of nanoparticle drug carriers using the pulsed high intensity focused ultrasound
- (2017) Sangmin Lee et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein
- (2017) Yulei Chen et al. Journal of Hematology & Oncology
- Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma
- (2017) T Fujishita et al. ONCOGENE
- Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
- (2017) Marco Ruella et al. Cancer Discovery
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- PARP inhibitors in ovarian cancer: evidence, experience and clinical potential
- (2017) Tarra Evans et al. Therapeutic Advances in Medical Oncology
- Investigation of Pericytes, Hypoxia, and Vascularity in Bladder Tumors: Association With Clinical Outcomes
- (2017) Martina B. O'Keeffe et al. ONCOLOGY RESEARCH
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors
- (2016) Lei Miao et al. CANCER RESEARCH
- Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice
- (2016) Lingxiang Kong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Hyaluronidase To Enhance Nanoparticle-Based Photodynamic Tumor Therapy
- (2016) Hua Gong et al. NANO LETTERS
- Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy
- (2016) Hao Zhou et al. NANO LETTERS
- Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
- (2016) Nako Maishi et al. Scientific Reports
- The PARP1 inhibitor BMN 673 exhibits immunoregulatory effects in a Brca1 −/− murine model of ovarian cancer
- (2015) Jing Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- The addition of recombinant vaccinia HER2/neu to oncolytic vaccinia-GMCSF given into the tumor microenvironment overcomes MDSC-mediated immune escape and systemic anergy
- (2015) C R de Vries et al. CANCER GENE THERAPY
- Oncolytic viruses: focusing on the tumor microenvironment
- (2015) C R de Vries et al. CANCER GENE THERAPY
- Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
- (2015) S. Takeuchi et al. CANCER RESEARCH
- CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
- (2015) J. Escamilla et al. CANCER RESEARCH
- Immunosuppression associated with chronic inflammation in the tumor microenvironment
- (2015) Dingzhi Wang et al. CARCINOGENESIS
- Molecular Connections between Cancer Cell Metabolism and the Tumor Microenvironment
- (2015) Calvin Justus et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune Checkpoint Blockade in Cancer Therapy
- (2015) Michael A. Postow et al. JOURNAL OF CLINICAL ONCOLOGY
- Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin
- (2015) Lei Miao et al. JOURNAL OF CONTROLLED RELEASE
- Tumor-Infiltrating Dendritic Cells in Cancer Pathogenesis
- (2015) Jo Marie Tran Janco et al. JOURNAL OF IMMUNOLOGY
- Moving targets: Emerging roles for MMPs in cancer progression and metastasis
- (2015) Gemma Shay et al. MATRIX BIOLOGY
- Nanoparticle Mediated Tumor Vascular Disruption: A Novel Strategy in Radiation Therapy
- (2015) Sijumon Kunjachan et al. NANO LETTERS
- CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
- (2015) Li Yang et al. Oncotarget
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
- (2015) F. Hossain et al. Cancer Immunology Research
- Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma
- (2015) Kyung-Ju Kim et al. PLoS One
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- Complexity and challenges in defining myeloid-derived suppressor cells
- (2014) Vera Damuzzo et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer
- (2014) Evgeniy B. Eruslanov et al. JOURNAL OF CLINICAL INVESTIGATION
- Tumor infiltrating B-cells are increased in prostate cancer tissue
- (2014) Jason R Woo et al. Journal of Translational Medicine
- Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression
- (2014) Damya Laoui et al. Frontiers in Immunology
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer
- (2013) James L. Gulley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma
- (2013) Manabu Shigeoka et al. CANCER SCIENCE
- Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cells
- (2013) Martin Franz Sprinzl et al. HEPATOLOGY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Dendritic Cells in the Cancer Microenvironment
- (2013) Yang Ma et al. Journal of Cancer
- Acidic tumor microenvironment and pH-sensing G protein-coupled receptors
- (2013) Calvin R. Justus et al. Frontiers in Physiology
- Pericyte Depletion Results in Hypoxia-Associated Epithelial-to-Mesenchymal Transition and Metastasis Mediated by Met Signaling Pathway
- (2012) Vesselina G. Cooke et al. CANCER CELL
- Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
- (2012) G. Erdag et al. CANCER RESEARCH
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
- (2012) Sergei I. Grivennikov et al. NATURE
- Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B
- (2012) Yu Sun et al. NATURE MEDICINE
- Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation
- (2011) Erin M. Bekes et al. AMERICAN JOURNAL OF PATHOLOGY
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Activation of Tumor-Promoting Type 2 Macrophages by EGFR-Targeting Antibody Cetuximab
- (2011) J. Pander et al. CLINICAL CANCER RESEARCH
- Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
- (2011) Annika Armulik et al. DEVELOPMENTAL CELL
- Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity
- (2011) Caroline Jochems et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Myeloid cell population dynamics in healthy and tumor-bearing mice
- (2011) Satoshi Ueha et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Treg cells: patrolling a dangerous neighborhood
- (2011) Daniel J Campbell et al. NATURE MEDICINE
- Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization
- (2011) Manav Korpal et al. NATURE MEDICINE
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Isolated tumor endothelial cells maintain specific character during long-term culture
- (2010) Kohei Matsuda et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
- (2010) Pauline Andreu et al. CANCER CELL
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Higher levels of GATA3 predict better survival in women with breast cancer
- (2010) Nam K. Yoon et al. HUMAN PATHOLOGY
- B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
- (2010) Massimo Ammirante et al. NATURE
- Estrogen or Estrogen Receptor Agonist Inhibits Lipopolysaccharide Induced Microglial Activation and Death
- (2010) Joshua A. Smith et al. NEUROCHEMICAL RESEARCH
- Cytogenetic Abnormalities of Tumor-Associated Endothelial Cells in Human Malignant Tumors
- (2009) Tomoshige Akino et al. AMERICAN JOURNAL OF PATHOLOGY
- Local and Distant Immunity Induced by Intralesional Vaccination with an Oncolytic Herpes Virus Encoding GM-CSF in Patients with Stage IIIc and IV Melanoma
- (2009) Howard L. Kaufman et al. ANNALS OF SURGICAL ONCOLOGY
- The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
- (2009) J. Ozao-Choy et al. CANCER RESEARCH
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non-Small Cell Lung Cancer
- (2008) K. I. Al-Shibli et al. CLINICAL CANCER RESEARCH
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy
- (2008) Nadia Guerra et al. IMMUNITY
- Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial
- (2008) Byeong-Ho Park et al. LANCET ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations
- (2008) K S M Smalley et al. ONCOGENE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years
- (2007) Bettina S. Nedergaard et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now